A nevus (plural: nevi) is the medical term for what most people call a mole — a cluster of pigment-producing cells called melanocytes that group together in the skin instead of spreading out evenly. Nearly every adult has at least a few, and most are completely harmless. But the word “nevus” actually covers a surprisingly wide family of skin growths, from the tiny brown dots that appear in childhood to large birthmarks present at birth, and understanding the differences matters because some types carry a meaningful risk of becoming melanoma while others almost never do.
Common Acquired Nevi
The moles that pop up during childhood and adolescence are called common acquired melanocytic nevi. They tend to be small, evenly colored, and round or oval with a well-defined border. Most adults end up with somewhere between 10 and 40 of them, though the number varies widely depending on genetics, skin tone, and how much sun exposure you had growing up.
Sun exposure during childhood appears to be one of the strongest drivers of how many moles you develop. A survey of Australian schoolchildren found that kids living closer to the equator had significantly more moles than those in southern cities, even after accounting for differences in skin color and freckling, suggesting that ambient UV radiation itself pushes mole development.1Journal of the American Academy of Dermatology. Sunlight: A major factor associated with the development of melanocytic nevi in Australian schoolchildren Another study found that moles cluster on body sites that receive strong intermittent sun rather than on areas that are constantly covered or constantly exposed, mirroring the same pattern seen in melanoma risk.2PubMed. Anatomic distribution of acquired melanocytic nevi in white children. A comparison with melanoma: the Vancouver Mole Study
Having lots of common moles is itself a risk factor for melanoma. A case-control study found that people with 100 or more nevi that were at least 2 mm in diameter had roughly eight times the melanoma risk of people with very few moles.3British Journal of Cancer. Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study That does not mean each individual mole is dangerous — it means a high mole count is a marker of sun sensitivity and melanocyte activity that, taken together, raise background risk.
Why Most Moles Never Become Cancer
If common moles share a key genetic mutation with melanoma, why do they almost always stay benign? The answer involves a built-in braking system. Most moles form when a melanocyte acquires a specific activating mutation in the BRAF gene. The same mutation (BRAF V600E) shows up in roughly half of all melanomas. Yet the vast majority of moles carrying this mutation will never progress to melanoma.4PubMed Central. Melanocytic nevi and melanoma: unraveling a complex relationship
The reason is that once BRAF V600E kicks in, the melanocyte essentially hits a permanent stop signal. The cell enters a state of growth arrest accompanied by markers of cellular aging, a process researchers call oncogene-induced senescence. Studies in human melanocytes have shown that sustained BRAF V600E expression triggers this arrest along with the production of well-known senescence markers, and crucially, the cells do not show signs of running out of replicative fuel — the stop is an active, protective process driven by the oncogene itself.5Nature. BRAFE600-associated senescence-like cell cycle arrest of human naevi Mouse experiments have confirmed that switching on BRAF V600E in melanocytes produces darkened skin and nevi filled with senescent cells.6Cancer Cell. Oncogenic Braf Induces Melanocyte Senescence and Melanoma in Mice
For a mole to become melanoma, additional hits have to bypass this brake. Loss of tumor-suppressor genes like p53 or CDKN2A can dismantle the senescence barrier, letting the melanocyte proliferate again.7PubMed Central. The role of BRAF mutation and p53 inactivation during transformation of a subpopulation of primary human melanocytes That chain of events is rare, which is why most moles simply sit there for decades without causing trouble.
Congenital Melanocytic Nevi
Some nevi are present at birth or appear within the first few weeks of life. These congenital melanocytic nevi (CMN) range from small spots a few millimeters across to giant lesions that can cover large portions of the trunk or limbs. They are classified primarily by projected adult size: small (under 1.5 cm), medium (1.5–20 cm), large (20–40 cm), and giant (over 40 cm).
The melanoma risk associated with congenital nevi depends heavily on size. A systematic review found that the risk in large-to-giant congenital nevi was roughly 22 times higher than in small-to-medium ones during the first 15 years of life.8PubMed. Risk of melanoma in congenital melanocytic nevi of all sizes: A systematic review Reported lifetime melanoma incidence in giant congenital nevi ranges from about 2% to as high as 31%, depending on the study and the way total nevus area is measured.9PubMed. Comparison of classification systems for congenital melanocytic nevi For small congenital nevi, the added risk remains poorly defined. The bottom line is that larger congenital nevi warrant closer monitoring, and many dermatologists recommend early and ongoing surveillance, while small congenital moles are usually managed like ordinary acquired moles.
Dysplastic (Atypical) Nevi
Dysplastic nevi sit in an uncomfortable gray zone between ordinary moles and melanoma. They tend to be larger than common moles, with irregular borders, uneven color, and a fried-egg appearance where the center is raised and the edges fade into the surrounding skin. Under the microscope, they show structural irregularities that pathologists grade as mild, moderate, or severe.
Since the term was coined in the 1970s, the dysplastic nevus has been a source of persistent disagreement among dermatologists and pathologists. A 1992 consensus conference recommended dropping the label altogether, yet the histologic diagnosis persists and still shapes clinical decisions.10PubMed Central. The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic, and clinical aspects The core controversy is whether a dysplastic nevus is a direct precursor that can morph into melanoma, or simply a marker that tells you the person’s skin is at elevated risk.
Current evidence leans toward the “marker” interpretation for most cases. A recent review concluded that most dysplastic nevi are not obligate precursors to melanoma but rather signal heightened risk overall. For mildly dysplastic nevi, clinical monitoring alone is generally appropriate. For severely dysplastic nevi, re-excision is typically recommended. Moderate dysplasia falls in between: if the biopsy shows clear margins and there is no visible residual lesion, observation is increasingly considered acceptable.11Current Dermatology Reports. Do All Dysplastic Nevi Need Re-Excision?
Less Common Types
Not all nevi involve the typical melanocytes you picture in a garden-variety mole. Several rarer types have distinct origins and behaviors worth knowing about.
Blue nevi get their color from melanocytes that sit deeper in the skin, in the dermis rather than near the surface. They are thought to arise from pigment cells that stalled during embryonic migration from the neural crest to the outer skin layers and accumulated in the wrong location.12PubMed Central. Blue Nevus Associated With Acquired Dermal Melanocytosis on the Back Most blue nevi are benign, small, and stable, though a rare variant called a cellular blue nevus can be harder to distinguish from melanoma on biopsy.
Spitz nevi are dome-shaped, pink or reddish-brown growths that mainly appear in children and young women. They can alarm both parents and clinicians because their appearance sometimes overlaps with melanoma. Intermediate forms, called atypical Spitz tumors, behave unpredictably and present one of dermatology’s trickiest diagnostic puzzles.13PubMed. Spitz Nevi and Other Spitzoid Neoplasms in Children: Overview of Incidence Data and Diagnostic Criteria Many dermatologists lean toward excision when a Spitz-like lesion occurs in an adult, simply because the overlap with melanoma is harder to rule out definitively.
Epidermal nevi are not melanocytic at all — they arise from overgrowth of skin cells other than melanocytes and often appear as velvety or warty streaks that follow characteristic curved lines on the body called Blaschko’s lines.14PubMed. Nevus marginatus: a distinct type of epidermal nevus or merely a variant of nevus sebaceus? Because they are not melanocytic, they carry no melanoma risk, though certain subtypes can be associated with other developmental conditions.
Familial Atypical Mole-Melanoma Syndrome
Some families carry an inherited predisposition to both atypical nevi and melanoma. The best-studied version is familial atypical multiple mole-melanoma (FAMMM) syndrome, which is most often linked to mutations in the CDKN2A gene. Roughly 5–10% of all melanomas occur in families with a hereditary predisposition, and CDKN2A mutations are found in about 20–40% of those families.15PubMed. Familial atypical multiple mole melanoma (FAMMM) syndrome: history, genetics, and heterogeneity
People with FAMMM syndrome often develop dozens of atypical nevi and face dramatically elevated melanoma risk. In high-UV environments like Australia, estimated lifetime melanoma risk for CDKN2A mutation carriers may reach over 50%, and some projections place it even higher.16Australasian Journal of Plastic Surgery. The management of hereditary melanoma, FAMMM syndrome and germline CDKN2A mutations: a narrative review These patients also face elevated risk of pancreatic cancer and other internal malignancies, which is why management often requires a multidisciplinary team rather than a dermatologist alone.17Journal of the American Academy of Dermatology. Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome
If you have a first-degree relative who was diagnosed with melanoma before age 40, or if multiple family members have had melanoma, it is worth discussing genetic counseling with your dermatologist. A confirmed CDKN2A mutation does not mean melanoma is inevitable, but it does justify more frequent full-body skin checks, often every three to six months.
When to See a Doctor
The most widely taught self-screening framework is the ABCDE rule: look for Asymmetry, Border irregularity, Color variation, Diameter larger than about 6 mm, and Evolution — any change in size, shape, or color over time. A related concept, sometimes called the “ugly duckling” sign, asks you to look for the one mole that does not look like the others.18PubMed Central. The ABCDEF Rule: Combining the “ABCDE Rule” and the “Ugly Duckling Sign” in an Effort to Improve Patient Self-Screening Examinations If most of your moles are small and tan but one is darker, larger, or shaped differently from the rest, that outlier deserves professional evaluation regardless of whether it technically meets each ABCDE criterion.
Beyond these patterns, specific symptoms that should prompt a visit include:
- Rapid change: A mole that clearly grows, darkens, or changes shape over weeks to months.
- New symptoms: Itching, bleeding, or crusting in a mole that was previously unremarkable.
- New mole after 30: Genuinely new pigmented lesions arising in middle age or later, as most acquired moles appear before age 30.
- Post-surgical recurrence: Pigment returning at the site of a previously removed mole.
When you see a dermatologist, a suspicious lesion is usually examined with a dermoscope, a handheld magnifying device with polarized light that reveals structures invisible to the naked eye. A meta-analysis found that clinical diagnosis of melanoma with the unaided eye is only about 60% accurate, while dermoscopy in experienced hands improved diagnostic accuracy by roughly 49%.19The Lancet Oncology. Accuracy of dermoscopy and a meta-analysis for cutaneous melanoma Among the specific dermoscopic features most predictive of melanoma, irregular pigmentation, blue-white veil, and atypical pigment network had the highest sensitivity, while pseudopods and shiny white structures had very high specificity.20JAMA Dermatology. Assessment of Diagnostic Accuracy of Dermoscopic Structures and Patterns Used in Melanoma Detection: A Systematic Review and Meta-analysis If a lesion looks worrisome under the dermoscope, the next step is a biopsy, which involves removing part or all of the mole so a pathologist can examine it under a microscope.21PubMed Central. Techniques of skin biopsy and practical considerations
Monitoring for High-Risk Patients
If you have a personal history of melanoma, FAMMM syndrome, or simply a large number of atypical moles, your dermatologist may recommend a structured surveillance program. One well-established approach combines total body photography (a set of standardized photos of your entire skin) with sequential dermoscopy, where individual moles are photographed at high magnification and compared side by side over time. This two-step method has been shown to catch melanomas at an early stage while keeping the number of unnecessary excisions low.22Journal of the American Academy of Dermatology. Benefits of total body photography and digital dermatoscopy (“two-step method of digital follow-up”) in the early diagnosis of melanoma in patients at high risk for melanoma
Artificial intelligence tools are increasingly entering this space. Deep-learning algorithms trained on clinical and dermoscopic images have achieved impressive accuracy in distinguishing melanoma from benign nevi. One observational study reported an area under the curve of 0.93 for an AI system, with sensitivity and specificity both around 85%.23PubMed Central. Detection of Malignant Melanoma Using Artificial Intelligence: An Observational Study of Diagnostic Accuracy However, the current consensus is that these tools work best as aids to human judgment rather than standalone diagnosticians — they are not yet refined enough for highly reliable diagnosis without clinician input.24PubMed Central. Recent Advances in Melanoma Diagnosis and Prognosis Using Machine Learning Methods Dermoscopy itself still requires experience to interpret well; the same meta-analysis that demonstrated its benefit also found that untrained examiners using a dermoscope performed no better than naked-eye inspection.19The Lancet Oncology. Accuracy of dermoscopy and a meta-analysis for cutaneous melanoma
How Pregnancy Affects Moles
One of the most common questions about nevi comes from pregnant people who notice their moles looking different. Hormonal shifts and skin stretching during pregnancy can change the size and color of existing moles, particularly on the abdomen and back. A case-control study found significant growth in moles on the abdomen and back between the first and second trimesters, with further abdominal growth in the third trimester. Pigmentation changes were also observed, though the direction depended on skin type — people with darker complexions were more likely to see increased pigmentation, while those with lighter skin sometimes saw moles lighten.25PubMed Central. NEVIGRAV Study: A Case–Control Analysis on Changes in Melanocytic Nevi During Pregnancy
Under dermoscopy, the most commonly reported change during pregnancy is an increase in the number of small dots and globules within moles, along with some network changes and occasionally new vascular structures.26Frontiers in Medicine. Dermatoscopic Features of Naevi During Pregnancy—A Mini Review A prospective study using AI-assisted dermoscopy tracked nearly 2,800 nevi and found that while moles in all women of childbearing age change somewhat over time, pregnant women showed larger increases in mole diameter, area, and number of colors, especially from the third trimester to postpartum.27PubMed Central. AI-assisted Total Body Dermoscopic Evaluation of Changes in Melanocytic Nevi during Pregnancy: A Prospective, Comparative Study of 2,799 Nevi
The reassuring finding across these studies is that pregnancy does not appear to increase the total number of moles or introduce worrisome new dermoscopic patterns like irregular streaks or structural asymmetry. The changes are mostly in size and pigment, and they tend to stabilize after delivery. Still, any mole that develops rapid asymmetric growth, irregular borders, or bleeding during pregnancy deserves the same evaluation it would get outside of pregnancy.
Halo Nevi and the Immune System
A halo nevus is a mole surrounded by a ring of lighter or completely depigmented skin. It looks striking and often concerns patients, but it is usually a sign that the immune system is actively dismantling the mole. Research indicates that the depigmentation is driven primarily by CD8+ T cells — immune cells that target and destroy melanocytes in much the same way they attack melanoma cells or melanocytes in the autoimmune condition vitiligo.28PubMed Central. Immunological aspects of halo nevus (Sutton’s Nevus) The abundance of antigen-presenting cells and T lymphocytes found at the depigmentation zone supports the idea that this is a genuine immune-mediated clearance process.29PubMed. The immune response in halo nevi
Halo nevi are most common in teenagers and young adults, and multiple halo nevi can appear simultaneously. In most cases, no treatment is needed — the mole gradually fades and may disappear entirely, with the surrounding skin eventually returning to its normal color. The one caveat is that in adults over 40 who suddenly develop a halo around a mole, a dermatologist should examine the lesion to rule out a regressing melanoma mimicking the halo phenomenon.
Living With Large or Visible Nevi
For children born with giant congenital nevi, the impact goes beyond medical risk. A study of 29 children with giant congenital melanocytic nevi found that 30% experienced social problems and about 26% had behavioral or emotional difficulties. Mothers reported considerable psychological burden as well, and neither the visibility of the nevus nor prior surgical treatment predicted whether problems would occur.30PubMed. Psychosocial sequelae in 29 children with giant congenital melanocytic naevi A larger study of parent reports found that children with congenital nevi had lower health-related quality of life compared to community norms, and that the strongest predictors of psychological difficulty were not the nevus’s size or whether surgery had been performed, but rather perceived stigmatization and skin-related discomfort like itching or pain.31Journal of Pediatric Psychology. Predictors of Health-related Quality of Life and Psychological Adjustment in Children and Adolescents With Congenital Melanocytic Nevi: Analysis of Parent Reports
These findings suggest that stigma and symptom management may matter more to a child’s well-being than the size of the lesion itself. Multidisciplinary care that includes psychological support for both the child and the family can improve outcomes.32Journal of Neonatology & Clinical Pediatrics. Giant Congenital Melanocytic Naevus: The Effect of Patient-Centered Multidisciplinary Approach on Quality of Life For families navigating decisions about surgical removal, it is worth knowing that surgery may reduce melanoma risk for some large congenital nevi but does not eliminate it entirely, and the psychological benefits of surgery are less clear-cut than many families hope.